Ads
related to: latest research on schizophrenia
Search results
Results from the WOW.Com Content Network
The U.S. Food and Drug Administration (FDA) on Friday approved a new drug used for treating schizophrenia in adults, according to a press release. “This drug takes the first new approach to ...
More than 40 percent of all people with schizophrenia end up in supervised group housing, nursing homes or hospitals. Another 6 percent end up in jail, usually for misdemeanors or petty crimes, while an equal proportion end up on the streets. Among researchers, schizophrenia has long been known as the “graveyard of psychiatric research.”
Kakar—a psychiatrist who treats patients as well as conducts research—says that historically, only about 40% of people with schizophrenia respond to dopamine-based treatments, and the other 60 ...
Schizophrenia Research is a peer-reviewed medical journal covering research on the cause, clinical diagnostics, and treatment of schizophrenia.It is an official journal of the Schizophrenia International Research Society and was established in 1988.
Ulotaront is in phase III clinical trial for schizophrenia, phase II/III for generalised anxiety disorder and major depressive disorder and discontinued for narcolepsy and psychotic disorders. [6] Research has shown that ulotaront results in a greater reduction from baseline in the PANSS total score than placebo. [7]
Schizophrenia Bulletin is a peer-reviewed medical journal which covers research relating to the etiology and treatment of schizophrenia. The journal is published bimonthly by Oxford University Press in association with the Maryland Psychiatric Research Center and Schizophrenia International Research Society .
Deficits in basic sensory functions influence higher-order processes such as auditory emotion recognition, perceptual closure, object recognition, etc. [11] New research also suggests that disruptions in basic visual and auditory processing could contribute to impaired social perception in schizophrenia, making it difficult for individuals to ...
The effectiveness of xanomeline/trospium chloride for the treatment of schizophrenia in adults was evaluated in two studies with identical designs. [2] Study 1 (NCT04659161) and study 2 (NCT04738123) were 5-week, randomized, double-blind, placebo-controlled, multi-center studies in adults with a diagnosis of schizophrenia according to DSM-5 ...
Ads
related to: latest research on schizophrenia